Further, studies focusing on cell-specific molecular perturbations demonstrated involvement in AD/ADRD of all brain cell types and identified many cell subtypes associated with risk or other endophenotypes of AD/ADRD, such as pathology or cognition (Cain et al., 2023
While not yet FDA approved, early clinical trials have shown promising results, with patients experiencing significant reductions in body weight over several months
Microdosing GLP-1 Medications What Is Microdosing GLP-1s
Subcutaneous injection delivers the highest systemic bioavailability and is preferred for anti-inflammatory, tissue-repair, and gene-modulation benefits
There is an issue with a significant imbalance between cytokines that promote and inhibit inflammation
Not all addictive substances may respond equally